Maxima Butterfly From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
- Coordinator
- Prinses Maxima Centrum Voor Kinderoncologie BV, Netherlands
- Runs
- 1 January 2023 to 31 December 2027
- Status
- Running
- EU funding
- €3.8m
- Total cost
- —
- Partners
- 49 organisations in 14 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101081481
What the project is doing
In the project's own words, from its summary on CORDIS.
Every year, around 600 children in the Netherlands get cancer and one in four children dies from this illness. More than ten years ago, a group of parents and healthcare professionals in the Netherlands started working towards one national children’s cancer centre that could accelerate advances in treatment by centralizing all patient care and research in one building. Those efforts led to the creation of the Princess Máxima Centre for paediatric oncology: a unique centre that brings together all the highly complex care and research for children with cancer in the Netherlands.
This concentration and integration of specialized paediatric oncology reflects our mission: ‘To provide a cure for every child with cancer while maintaining an optimal quality of life’. Only with innovative research we will be able to improve survival and quality of life for children with cancer. Our research covers the entire spectrum: from fundamental research to expose genetic and molecular characteristics of tumour cells to clinical trials to test improved treatment options.
And from translational experiments to develop personalized therapy to psychosocial studies that monitor the wellbeing of the whole family. Collaborations within our center, between researchers and clinicians, but also partnerships with other institutes, nationally and internationally, are crucial to reach our goals. To contribute to this effort, the MAXIMA-BUTTERFLY programme will train the next generation of multi-disciplinary scientists in the field of paediatric oncology.
For a successful implementation and to achieve a radical change in the society, the work needs to be translated to the academic community, the industry, health policy makers, regulatory authorities, insurance companies, doctors, patients, patients advocates, and the general public. Therefore, a multidisciplinary research team of scientists based in the Princess Máxima Centre are applying for a Marie Skłodowska-Curie COFUND grant for 28 DCs.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Prinses Maxima Centrum Voor Kinderoncologie BV | Utrecht | Netherlands | Coordinator |
| Institut Fuer Molekulare Biotechnologie GmbH | Wien | Austria | Associatedpartner |
| St. Anna Kinderkrebsforschung GmbH | Wien | Austria | Associatedpartner |
| Murdoch Children's Research Institute | Melbourne | Australia | Associatedpartner |
| Katholieke Universiteit Leuven | Leuven | Belgium | Associatedpartner |
| Universiteit Gent | Gent | Belgium | Associatedpartner |
| F. Hoffmann-La Roche AG | Basel | Switzerland | Associatedpartner |
| Universitat Zurich | Zurich | Switzerland | Associatedpartner |
| Fakultni Nemocnice Motol a Homolka | Praha 5 | Czechia | Associatedpartner |
| Charles River Discovery Research Services Germany GmbH | Freiburg | Germany | Associatedpartner |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Associatedpartner |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Associatedpartner |
| Klinikum Oldenburg gGmbH | Oldenburg | Germany | Associatedpartner |
| Fundacio Institut De Recerca Contra La Leucemia Josep Carreras | Badalona | Spain | Associatedpartner |
| Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii | Madrid | Spain | Associatedpartner |
| Universidad De Navarra | Pamplona | Spain | Associatedpartner |
| Innovative Therapies for Children with Cancer Association | Villejuif | France | Associatedpartner |
| Institut Curie | Paris | France | Associatedpartner |
| Therapanacea | Paris | France | Associatedpartner |
| Xentech SAS | Evry | France | Associatedpartner |
| Fondazione Human Technopole | Milano | Italy | Associatedpartner |
| Scientific Directorate Research Unit for Multifactorial Disease Bambino Gesu Childrens Hospital | Rome | Italy | Associatedpartner |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Associatedpartner |
| Crown Bioscience Netherlands BV | Leiden | Netherlands | Associatedpartner |
| Cyclomics BV | Amsterdam | Netherlands | Associatedpartner |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Associatedpartner |
| Mimetas BV | Leiden | Netherlands | Associatedpartner |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Associatedpartner |
| Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | Associatedpartner |
| Stichting Hubrecht Organoid Technology | Utrecht | Netherlands | Associatedpartner |
| Stichting Sanquin Bloedvoorziening | Amsterdam | Netherlands | Associatedpartner |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Associatedpartner |
| Universiteit Utrecht Holding BV | Utrecht | Netherlands | Associatedpartner |
| Vereniging Kinderkanker Nederland | De Bilt | Netherlands | Associatedpartner |
| Xilis BV | Utrecht | Netherlands | Associatedpartner |
| Region Skane | Kristianstad | Sweden | Associatedpartner |
| Narodny Ustav Detskych Chorob | Bratislava | Slovakia | Associatedpartner |
| Astrazeneca UK Limited | Cambridge | United Kingdom | Associatedpartner |
| Great Ormond Street Hospital for Children Nhs Foundation Trust | London | United Kingdom | Associatedpartner |
| Solving Kids Cancer UK Ltd | London | United Kingdom | Associatedpartner |
| University College London | London | United Kingdom | Associatedpartner |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
| Regents of the University of Michigan | Ann Arbor | United States | Associatedpartner |
| St. Jude Children's Research Hospital | Memphis | United States | Associatedpartner |
| The Regents of the University of California | Oakland | United States | Associatedpartner |
| The Nemours Foundation | Wilmington | United States | Associatedpartner |
| University of Tennessee | Memphis | United States | Associatedpartner |
| Virginia Commonwealth University | Richmond, VA | United States | Associatedpartner |
| Whitehead Institute for Biomedical Research | Cambridge | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI